Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
705
-
Total 13F shares, excl. options
-
95.1M
-
Shares change
-
-921K
-
Total reported value, excl. options
-
$19.8B
-
Value change
-
-$194M
-
Put/Call ratio
-
0.57
-
Number of buys
-
304
-
Number of sells
-
-264
-
Price
-
$208.13
Significant Holders of RESMED INC - Common Stock (RMD) as of Q4 2022
763 filings reported holding RMD - RESMED INC - Common Stock as of Q4 2022.
RESMED INC - Common Stock (RMD) has 705 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.1M shares
of 146M outstanding shares and own 64.91% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (16.5M shares), BlackRock Inc. (13.2M shares), FMR LLC (6.81M shares), STATE STREET CORP (6.36M shares), Capital World Investors (5.05M shares), WCM INVESTMENT MANAGEMENT, LLC (3.83M shares), GEODE CAPITAL MANAGEMENT, LLC (3.13M shares), NORTHERN TRUST CORP (1.86M shares), Invesco Ltd. (1.86M shares), and Ownership Capital B.V. (1.41M shares).
This table shows the top 705 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.